Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol

Lecithin:cholesterol acyltransferase (LCAT) and LCAT-activating compounds are being investigated as treatments for coronary heart disease (CHD) and familial LCAT deficiency (FLD). Herein we report the crystal structure of human LCAT in complex with a potent piperidinylpyrazolopyridine activator and...

Full description

Bibliographic Details
Main Authors: Kelly A Manthei, Shyh-Ming Yang, Bolormaa Baljinnyam, Louise Chang, Alisa Glukhova, Wenmin Yuan, Lita A Freeman, David J Maloney, Anna Schwendeman, Alan T Remaley, Ajit Jadhav, John JG Tesmer
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2018-11-01
Series:eLife
Subjects:
LCAT
HDL metabolism
high density lipoprotein
lecithin cholesterol acyltransferase
cholesterol
Online Access:https://elifesciences.org/articles/41604

Internet

https://elifesciences.org/articles/41604

Similar Items